Paul Hartmann AG Logo

Paul Hartmann AG

Provides medical and hygiene solutions for wound, incontinence, and infection management.

PHH2 | F

Overview

Corporate Details

ISIN(s):
DE0007474041
LEI:
5493008OWN3GUZK1EW25
Country:
Germany
Address:
Paul-Hartmann-Straße 12, 89522 Heidenheim an der Brenz
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Paul Hartmann AG, operating as the HARTMANN GROUP, is a leading international provider of medical and hygiene products and system solutions. With a history spanning over 200 years, the company's core business is organized into three primary segments: Wound Management, Incontinence Management, and Infection Management. Its portfolio includes therapeutic bandages, first aid supplies, discreet incontinence solutions, and products for risk prevention. HARTMANN serves both medical professionals and private customers, aiming to deliver solutions that are economically beneficial and simplify care for patients and caregivers. The company also develops digital services and business models to complement its core offerings.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-28 00:00
Annual / Quarterly Financial Statement
Konzernabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
German 681.8 KB
2025-10-06 00:00
Annual / Quarterly Financial Statement
Datum:06.10.2025
German 478.9 KB
2025-04-25 16:46
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, buy
English 6.0 KB
2025-04-22 00:00
Annual / Quarterly Financial Statement
Ergänzung der Veröffentlichung vom 08.08.2023
German 8.6 KB
2024-11-07 00:00
Annual / Quarterly Financial Statement
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
German 737.8 KB
2024-09-30 00:00
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
German 313.3 KB
2024-08-19 15:46
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, buy
English 7.8 KB
2024-08-13 00:00
Interim Report
Halbjahresabschluss 2024
German 232.3 KB
2024-03-19 00:00
Annual Report
Jahresabschluss 2023
German 4.1 MB
2024-02-02 17:17
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.5 KB
2024-02-02 17:13
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.5 KB
2024-02-02 17:08
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.0 KB
2024-02-02 17:05
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 9.3 KB
2024-02-02 17:00
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.0 KB
2024-02-02 16:55
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.9 KB

Automate Your Workflow. Get a real-time feed of all Paul Hartmann AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Paul Hartmann AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Paul Hartmann AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-08-19 SCHWENK Limes GmbH & Co. KG Close relation Buy None 201,400.00 EUR
2024-02-02 SCHWENK Limes GmbH & Co. KG Close relation Buy None 72,000.00 EUR
2024-02-02 SCHWENK Limes GmbH & Co. KG Close relation Buy None 71,750.00 EUR
2024-02-02 SCHWENK Limes GmbH & Co. KG Close relation Buy None 70,200.00 EUR
2024-02-02 SCHWENK Limes GmbH & Co. KG Close relation Buy None 68,472.00 EUR
2024-02-01 SCHWENK Limes GmbH & Co. KG Close relation Buy None 127,800.00 EUR
2024-02-01 SCHWENK Limes GmbH & Co. KG Close relation Buy None 70,500.00 EUR
2024-02-01 SCHWENK Limes GmbH & Co. KG Close relation Buy None 69,000.00 EUR
2024-02-01 SCHWENK Limes GmbH & Co. KG Close relation Buy None 63,280.00 EUR
2024-02-01 SCHWENK Limes GmbH & Co. KG Close relation Buy None 63,000.00 EUR

Peer Companies

TRINITY BIOTECH PLC Logo
Develops and markets clinical diagnostic test kits and biosensors for labs and point-of-care.
United States of America
TRIB
TriSalus Life Sciences, Inc. Logo
Oncology tech firm enhancing drug delivery and immunotherapy for solid liver & pancreas tumors.
United States of America
TLSI
Developing disruptive, pre-approval technologies for the spinal stabilization market.
United Kingdom
TSP
Twist Bioscience Corp Logo
Offers scalable DNA synthesis on silicon for research, drug discovery, and diagnostics.
United States of America
TWST
UFP TECHNOLOGIES INC Logo
Designs & manufactures custom products from advanced materials for MedTech, aerospace & auto markets.
United States of America
UFPT
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy
UBM
UTAH MEDICAL PRODUCTS INC Logo
Develops specialty medical devices to improve healthcare outcomes for women and their babies.
United States of America
UTMD
UXN Co., Ltd. Logo
Develops advanced continuous glucose monitoring systems and sensors for diabetes management.
South Korea
337840
Venus Concept Inc. Logo
Develops aesthetic & hair restoration systems for professionals on a subscription model.
United States of America
VERO
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany
VMED

Talk to a Data Expert

Have a question? We'll get back to you promptly.